Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)
Clinical trial NCT01915524 · TERMINATED
Trial details
- NCT number
- NCT01915524
- Sponsor
- CureVac
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-07-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.